Expert Consensus Statement
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

https://doi.org/10.1016/j.echo.2014.07.012Get rights and content

Keywords

Chemotherapy
Doxorubicin
Trastuzumab
Left ventricular dysfunction
Three-dimensional echocardiography
Early detection
Strain
Biomarkers

Abbreviations

ASE
American Society of Echocardiography
BNP
Brain-type natriuretic peptide
CAD
Coronary artery disease
CMR
Cardiac magnetic resonance
CTRCD
Cancer therapeutics–related cardiac dysfunction
DTI
Doppler tissue imaging
EACVI
European Association of Cardiovascular Imaging
EAE
European Association of Echocardiography
GLS
Global longitudinal strain
HF
Heart failure
LGE
Late gadolinium enhancement
LV
Left ventricular
LVEF
Left ventricular ejection fraction
MUGA
Multigated blood pool imaging
NT-proBNP
N-terminal pro–B-type natriuretic peptide
RV
Right ventricular
STE
Speckle-tracking echocardiography
3D
Three-dimensional
3DE
Three-dimensional echocardiography
TnI
Troponin I
2D
Two-dimensional
2DE
Two-dimensional echocardiography
VEGF
Vascular endothelial growth factor

Cited by (0)

The following authors reported no actual or potential conflicts of interest in relation to this document: Juan Carlos Plana, MD, FASE, Maurizio Galderisi, MD, FESC, Marielle Scherrer-Crosbie, MD, PhD, FASE, Javier Ganame, MD, PhD, FASE, Deborah A. Agler, RCT, RDCS, FASE, Luigi P. Badano, MD, PhD, FESC, Jose Banchs, MD, FASE, Daniela Cardinale, MD, Joseph Carver, MD, Thor Edvardsen, MD, PhD, FESC, Brian Griffin, MD, Guy Jerusalem, MD, PhD, Jennifer E. Liu, MD, FASE, Andreia Magalhães, MD, Liza Y. Sanchez, RCS, FASE, Rosa Sicari, MD, PhD, FESC, Hector R. Villarraga, MD, FASE, and Patrizio Lancellotti, MD, PhD, FESC. The following authors reported relationships with one or more commercial interests: Ana Barac, MD, received research funding and lectures honoraria from Genentech and consultancy fees from Cell Therapeutics. Manuel Cerqueira, MD, received a grant from Perceptive Informatics, Inc; consults for GE Healthcare, FluoroPharma and Astellas; and serves on the speakers bureau for Astellas. Jeanne M. DeCara, MD, served as a consultant for Epsilon Imaging and Methylgene. Michael S. Ewer, MD, JD, consults or serves as advisory board member for Roche Laboratories, Cell Therapeutics, GlaxoSmithKline, and Boehringer Ingelheim. Scott D. Flamm, MD, MBA, serves on advisory boards for Philips Healthcare, Bayer Healthcare, and TeraRecon and received institutional research support from Siemens Healthcare. Thomas Force, MD consults for GlaxoSmithKline. Bonnie Ky, MD, FASE, received an investigator-initiated award from Pfizer, Inc. Thomas Marwick, MBBS, PhD, MPH, received research funding from the National Health and Medical Research Council in Australia and the Royal Hobart Hospital Foundation, an equipment grant from Philips Medical Systems and Siemens, and a project grant from GE Medical Systems. Igal A. Sebag, MD, FASE, serves on the speakers bureau for Lantheus.

Reprint requests: American Society of Echocardiography, 2100 Gateway Centre Boulevard, Suite 310, Morrisville, NC 27560 (E-mail: [email protected]).

View Abstract